Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 25, 2026 22:56 ET | Source: InnoCare Pharma

InnoCare Announces Key Developments of Critical Clinical Studies

InnoCare announced key clinical development progress, including the completion of patient enrollment of multiple Phase III registrational trials.
December 23, 2025 05:00 ET | Source: InnoCare Pharma

InnoCare Announces NMPA Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Cutaneous Lupus Erythematosus

CLE is the second indication InnoCare is developing for ICP-488, and enrollment for the phase III study of ICP-488 for psoriasis is nearing completion.